How do I buy Arcutis Biotherapeutics (ARQT) stock?

You can purchase shares of Arcutis Biotherapeutics (NASDAQ:ARQT) through any online brokerage.View our list of the best stock brokerages

Who are Arcutis Biotherapeutics (ARQT) competitors?

Other companies in Arcutis Biotherapeutics’s space includes: IDEAYA Biosciences Inc (NASDAQ:IDYA), Legend Biotech Corp (NASDAQ:LEGN), Centessa Pharmaceuticals PLC (NASDAQ:CNTA), Xenon Pharmaceuticals Inc (NASDAQ:XENE) and TG Therapeutics Inc (NASDAQ:TGTX).

What is the forecast, or price target, for Arcutis Biotherapeutics (ARQT) stock?

Arcutis Biotherapeutics has a consensus price target of $27.91.

What is the current price for Arcutis Biotherapeutics (ARQT)?

The stock price for Arcutis Biotherapeutics (NASDAQ: ARQT) is $26.08 last updated January 13, 2026 at 7:30 PM EST.

Does Arcutis Biotherapeutics (ARQT) pay a dividend?

There are no upcoming dividends for Arcutis Biotherapeutics.

When is Arcutis Biotherapeutics (NASDAQ:ARQT) reporting earnings?

Arcutis Biotherapeutics does not have any upcoming earnings scheduled.

Is Arcutis Biotherapeutics (ARQT) going to split?

There is no upcoming split for Arcutis Biotherapeutics.

What sector and industry does Arcutis Biotherapeutics (ARQT) operate in?

Arcutis Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Arcutis Biotherapeutics (ARQT) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentia...

Comments